High Intensity Health - New Blood Sugar Health Testing
The speaker emphasizes the limitations of the hemoglobin A1c test due to variability in red blood cell breakdown, suggesting alternative biomarkers for more accurate blood sugar monitoring. These include the fructosamine test and the 15 AG (15 anhydroglucitol) test, which provide better short-term glucose control insights. The importance of measuring fasting insulin, glucose, and triglycerides is highlighted, alongside the APO B to APO A1 ratio for lipid health. Practical advice includes fasting for at least 12 hours before a lipid panel and considering non-fasted tests to understand post-meal blood sugar and lipid levels. The speaker also discusses the impact of diet and exercise on these biomarkers, suggesting that moderate carbohydrate intake and regular physical activity can help maintain healthy levels.
Key Points:
- Consider fructosamine and 15 AG tests for better short-term glucose monitoring.
- Measure fasting insulin, glucose, and triglycerides for comprehensive metabolic health assessment.
- Use APO B to APO A1 ratio for a better understanding of lipid health.
- Fast for at least 12 hours before a lipid panel; consider non-fasted tests for post-meal insights.
- Regular exercise and moderate carb intake can help maintain healthy metabolic markers.
Details:
1. 🔴 Welcome to Metabolic Tuesday!
1.1. Session Overview
1.2. Key Topics
1.3. Audience Engagement and Q&A
2. 🩺 Common Blood Work Pitfalls
2.1. Common Pitfalls in Blood Glucose Interpretation
2.2. Contextual Considerations in Lipid Profiles
2.3. Thyroid Level Variance Interpretation
3. 📉 Beyond Hemoglobin A1C: Better Biomarkers
- Explore alternative biomarkers beyond traditional Hemoglobin A1C tests to improve diabetes management.
- Identify innovative methods in biomarker identification that offer more precise and comprehensive health insights.
- Highlight specific examples of new biomarkers that outperform A1C in predicting and managing diabetes, such as continuous glucose monitoring (CGM) metrics and advanced glycation end products (AGEs).
- Discuss the limitations of Hemoglobin A1C, such as its inability to capture short-term blood glucose fluctuations and its varied accuracy across different populations, underscoring the need for more reliable biomarkers.
4. 🔎 Advanced Blood Sugar Testing Methods
- Biomarkers available are more sensitive and specific than traditional hemoglobin A1c and LDL cholesterol tests.
- The use of APO B to APO A1 ratios is recommended for better accuracy in assessing cardiovascular risks.
- Advanced biomarkers provide a more comprehensive understanding of an individual's health status and can lead to more personalized treatment plans.
- These biomarkers can detect changes earlier than traditional methods, allowing for timely interventions.
- Incorporating these biomarkers into regular testing routines can enhance the monitoring and management of diabetes and cardiovascular health.
5. 💬 Engaging with the Audience
5.1. Alternative Blood Glucose Tests
5.2. Audience Engagement Strategies
6. 📊 Limitations of Hemoglobin A1C
- The hemoglobin A1C test is widely used for monitoring long-term blood sugar control, but it has notable limitations, particularly in its variability across different individuals.
- The accuracy of the A1C test can be affected by individual differences in the breakdown of red blood cells and hemoglobin, leading to potential inaccuracies in glucose measurement.
- This variability might result in misleading A1C results, which can significantly impact diabetes management and treatment plans by presenting an inaccurate picture of a patient's blood sugar control.
- Factors contributing to variability include differences in red blood cell lifespan, genetic traits, and certain medical conditions like anemia, which can skew results.
- This issue is particularly pronounced in certain populations, such as those with sickle cell disease or those from specific ethnic backgrounds, where hemoglobin variants are more common.
7. 🔬 Exploring New Blood Sugar Tests
- The current skepticism regarding the effectiveness of hemoglobin A1c in accurately reflecting blood sugar levels has led to the exploration of Glycomark as a promising alternative.
- Glycomark, also referred to as 15 AG or 15 anhydroglucitol, offers a more precise short-term biomarker for blood sugar levels compared to hemoglobin A1c.
- This test measures a secretory product from the kidneys, which provides an advantage over traditional glucose monitoring by offering a different perspective on glucose management.
- By focusing on short-term glucose fluctuations, Glycomark can potentially enhance the clinical management of blood sugar levels, providing a clearer picture of a patient's glucose control over recent weeks.
- The introduction of Glycomark could lead to improved patient outcomes by allowing for more tailored treatment plans based on real-time glucose variations.
8. 📝 Comprehensive Lab Tests for Glucose Monitoring
- Evaluate non-traditional biomarkers for better glucose control, including fructosamine and hemoglobin A1c.
- Focus on fasting insulin, glucose, fructosamine, and hemoglobin A1c for comprehensive glucose monitoring.
- Fructosamine provides an average glucose level over the past 2-3 weeks, offering a more immediate reflection compared to hemoglobin A1c.
- Hemoglobin A1c measures long-term glucose control by reflecting average glucose levels over 2-3 months, crucial for assessing diabetes management.
- Fasting insulin levels give insight into insulin resistance, an early indicator of potential glucose management issues.
9. 🤔 Audience Questions: Blood Sugar Levels
- A1c and fructosamine are effective in providing insights into glucose levels, helping in monitoring long-term blood sugar management.
- An A1C level of 5.6 is generally considered acceptable, indicating good blood sugar control over the past three months.
- Fasting insulin levels should ideally be around four or five for optimal metabolic health, even though a level of seven is acceptable. Lower insulin levels often signify better insulin sensitivity and reduced risk of metabolic disorders.
10. 🧠 Insulin and Glucose Variability
- A1C level at 5.6 is considered safe, but there is a need to lower fasting glucose levels for better health outcomes.
- Insulin levels exhibit significant daily variability due to factors like recent meals and physical activity, making them less reliable for short-term monitoring.
- Markers like 15 AG provide better predictions for short-term blood sugar control over a two-week period, offering more stability compared to insulin measurements.
- Understanding these markers can help tailor personalized treatment plans and improve patient outcomes by focusing on consistent blood sugar management.
11. 🔍 Non-Fasted Blood Work Insights
- The glycomark test, offered by Labore, assesses 15 AG forosamine hemoglobin A1c to monitor short-term glucose control, providing an additional layer of information beyond traditional A1c tests.
- Insulin levels: A fasting insulin level of 7 is within the acceptable range of 0 to 20, indicating no immediate concern. However, in metabolically healthy individuals, levels should ideally be around 4 or 5, suggesting room for optimization.
- Fasting glucose: The ideal fasting glucose level should be in the low 80s, which is indicative of optimal metabolic health. Deviations from this range can signal potential metabolic issues.
12. 🧬 Understanding Lipid Ratios and Heart Health
- After sauna sessions, blood glucose levels increase, but it is crucial to focus on avoiding prolonged elevations rather than minor, temporary increases.
- For lipid panel testing, it is recommended to fast for at least 12 hours to establish a baseline of fasted metabolic health, including lipids, glucose, and A1C levels.
- Non-fasted lipid testing, particularly for triglycerides, should be considered to understand the lipid load; this involves eating a standard meal and testing blood 90 minutes after.
- A comprehensive view of metabolic health can be achieved by comparing both fasted and postmeal bloodwork, focusing on triglycerides, glucose, and insulin levels to assess heart health risks.
13. 🏃♂️ Exercise, Diet, and APO Levels
- Cardiovascular disease typically occurs in the postmeal window, not during fasting or fasted exercise. It's crucial to monitor blood markers both in fasted and non-fasted states for a comprehensive understanding of cardiovascular health.
- Initial laboratory tests should be conducted after 12 hours of fasting, followed by a high-fat meal to observe changes in blood triglycerides in the postmeal window. This approach helps in understanding how dietary habits impact cardiovascular risk.
- The APO to APO A1 ratio is an important metric to evaluate during these tests, as it provides insights into lipid metabolism and cardiovascular risk. Monitoring these ratios can guide dietary and lifestyle interventions.
- Resources such as a blood work cheat sheet are available through Myoscience.com to assist in understanding and managing these health markers, offering practical guidance for individuals seeking to optimize their cardiovascular health.
14. 📈 Evaluating Blood Work with APO Ratios
- APO B is often not measured in routine blood work, which can overlook important cardiovascular health indicators. It is present on the surface of all atherogenic lipoproteins, such as LDL and VLDL, highlighting its significance.
- The APO B to APO A1 ratio is crucial for understanding the balance between LDL and HDL, providing insights into lipoprotein health and associated cardiovascular risks.
- Testing for both APO B and APO A1 concurrently is essential for a comprehensive assessment of cardiovascular risk, as it offers a clearer picture than traditional lipid profiles alone.
- Additional tests such as LP(a) and fibrinogen should be considered to complement lipid profiles, as they provide further insights into cardiovascular risk.
- Interpreting APO B levels, like a reported value of 142, should be done alongside APO A1 levels to derive actionable health insights.
- Phenomenal metabolic health indicators include fructosamine levels at 235 and fasting insulin at 38, which suggest positive outcomes.
15. 🧪 Exploring Additional Biomarkers
15.1. Biomarker Ratios and Tests
15.2. Impact of Diet on Biomarkers
15.3. Additional Biomarker Considerations
16. 💪 Aging, Activity, and Metabolic Health
16.1. B12 and Liver Supplements
16.2. Aging and Metabolic Biomarkers
16.3. Red Blood Cell Life Cycle and Glucose Levels
17. 👶 B12 Levels, Pregnancy, and Health Considerations
- Monitor B12 levels during pregnancy, particularly for individuals with diabetes, to mitigate potential health risks associated with deficiency.
- B12 deficiency can be indirectly indicated by elevated malonic acid levels, suggesting the need for liver supplements or dietary adjustments.
- Regular screening of B12 levels in pregnant individuals is crucial to prevent complications that could arise from deficiency, including neurological issues in the baby.
- Consider dietary sources rich in B12 or supplements if levels are found to be low, ensuring both maternal and fetal health.